Atlas Trials

An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma

Clinical trial NCT04586244 · TERMINATED

Trial details

NCT number
NCT04586244
Sponsor
Incyte Corporation
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Urothelial Carcinoma
Start date
2022-01-14
Primary completion
2024-01-29
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.